BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. The unique characteristics of COVID-19 coagulopathy. Crit Care. 2020;24:360. [PMID: 32552865 DOI: 10.1186/s13054-020-03077-0] [Cited by in Crossref: 146] [Cited by in F6Publishing: 131] [Article Influence: 73.0] [Reference Citation Analysis]
Number Citing Articles
1 Stelzer M, Henes J, Saur S. The Role of Antiphospholipid Antibodies in COVID-19. Curr Rheumatol Rep 2021;23:72. [PMID: 34259944 DOI: 10.1007/s11926-021-01041-7] [Reference Citation Analysis]
2 Levy JH, Iba T, Olson LB, Corey KM, Ghadimi K, Connors JM. COVID-19: Thrombosis, thromboinflammation, and anticoagulation considerations. Int J Lab Hematol 2021;43 Suppl 1:29-35. [PMID: 34288441 DOI: 10.1111/ijlh.13500] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Tsyganova EV, Glukhoedova NV, Zhilenkova AS, Fedoseeva TI, Iushchuk EN, Smetneva NS. COVID-19 and features of cardiovascular involvement. Terapevticheskii arkhiv 2021;93:1091-9. [DOI: 10.26442/00403660.2021.09.201036] [Reference Citation Analysis]
4 Daher A, Balfanz P, Cornelissen C, Müller A, Bergs I, Marx N, Müller-Wieland D, Hartmann B, Dreher M, Müller T. Follow up of patients with severe coronavirus disease 2019 (COVID-19): Pulmonary and extrapulmonary disease sequelae. Respir Med 2020;174:106197. [PMID: 33120193 DOI: 10.1016/j.rmed.2020.106197] [Cited by in Crossref: 44] [Cited by in F6Publishing: 44] [Article Influence: 22.0] [Reference Citation Analysis]
5 Mei ZW, van Wijk XMR, Pham HP, Marin MJ. Role of von Willebrand Factor in COVID-19 Associated Coagulopathy. J Appl Lab Med 2021:jfab042. [PMID: 33930144 DOI: 10.1093/jalm/jfab042] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Sandor-Keri J, Benedek I, Polexa S, Benedek I. The Link between SARS-CoV-2 Infection, Inflammation and Hypercoagulability-Impact of Hemorheologic Alterations on Cardiovascular Mortality. J Clin Med 2021;10:3015. [PMID: 34300181 DOI: 10.3390/jcm10143015] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Alabyad D, Rangaraju S, Liu M, Imran R, Kempton CL, Sharifpour M, Auld SC, Gaddh M, Sniecinski R, Maier CL, Guarner J, Duncan A, Nahab F. Validation of an admission coagulation panel for risk stratification of COVID-19 patients. PLoS One 2021;16:e0248230. [PMID: 33740793 DOI: 10.1371/journal.pone.0248230] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Bastopcu M. Extensive Arterial Thrombus Following Discharge after a Covid-19 Infection. Ann Vasc Surg 2021;72:205-8. [PMID: 33333188 DOI: 10.1016/j.avsg.2020.11.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
9 Kolesova O, Vanaga I, Laivacuma S, Derovs A, Kolesovs A, Radzina M, Platkajis A, Eglite J, Hagina E, Arutjunana S, Putrins DS, Storozenko J, Rozentale B, Viksna L. Intriguing findings of liver fibrosis following COVID-19. BMC Gastroenterol 2021;21:370. [PMID: 34635073 DOI: 10.1186/s12876-021-01939-7] [Reference Citation Analysis]
10 Goswami J, MacArthur TA, Sridharan M, Pruthi RK, McBane RD 2nd, Witzig TE, Park MS. A Review of Pathophysiology, Clinical Features, and Management Options of COVID-19 Associated Coagulopathy. Shock 2021;55:700-16. [PMID: 33378321 DOI: 10.1097/SHK.0000000000001680] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
11 Desai AD, Boursiquot BC, Melki L, Wan EY. Management of Arrhythmias Associated with COVID-19. Curr Cardiol Rep 2020;23:2. [PMID: 33231782 DOI: 10.1007/s11886-020-01434-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
12 Tamayo-Velasco Á, Bombín-Canal C, Cebeira MJ, Sánchez-De Prada L, Miramontes-González JP, Martín-Fernández M, Peñarrubia-Ponce MJ. Full Characterization of Thrombotic Events in All Hospitalized COVID-19 Patients in a Spanish Tertiary Hospital during the First 18 Months of the Pandemic. J Clin Med 2022;11:3443. [PMID: 35743512 DOI: 10.3390/jcm11123443] [Reference Citation Analysis]
13 Zhang J, Huang X, Ding D, Tao Z. Platelet-driven coagulopathy in COVID-19 patients: in comparison to seasonal influenza cases. Exp Hematol Oncol 2021;10:34. [PMID: 34059141 DOI: 10.1186/s40164-021-00228-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Blot M, de Maistre E, Bourredjem A, Quenot JP, Nguyen M, Bouhemad B, Charles PE, Binquet C, Piroth L. Specific Features of the Coagulopathy Signature in Severe COVID-19 Pneumonia. Front Med (Lausanne) 2021;8:675191. [PMID: 34422854 DOI: 10.3389/fmed.2021.675191] [Reference Citation Analysis]
15 Habashi NM, Camporota L, Gatto LA, Nieman G. Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications. J Appl Physiol (1985) 2021;130:877-91. [PMID: 33444117 DOI: 10.1152/japplphysiol.00742.2020] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
16 Emmenegger M, Kumar SS, Emmenegger V, Malinauskas T, Buettner T, Rose L, Schierack P, Sprinzl MF, Sommer CJ, Lackner KJ, Aguzzi A, Roggenbuck D, Frauenknecht KBM. Anti-prothrombin autoantibodies enriched after infection with SARS-CoV-2 and influenced by strength of antibody response against SARS-CoV-2 proteins. PLoS Pathog 2021;17:e1010118. [PMID: 34860860 DOI: 10.1371/journal.ppat.1010118] [Reference Citation Analysis]
17 de Cortina Camarero C, Gómez Mariscal E, Espejo Bares V, Núñez Garcia A, Muñoz Aguilera R, Botas Rodriguez J. [SARS-CoV-2 infection: A predisposing factor for acute coronary syndrome]. Med Clin (Barc) 2021;157:114-7. [PMID: 33632511 DOI: 10.1016/j.medcli.2021.01.004] [Reference Citation Analysis]
18 Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. An Interactive Single Cell Web Portal Identifies Gene and Cell Networks in COVID-19 Host Responses. iScience 2021;:103115. [PMID: 34522848 DOI: 10.1016/j.isci.2021.103115] [Reference Citation Analysis]
19 Prokop JW, Hartog NL, Chesla D, Faber W, Love CP, Karam R, Abualkheir N, Feldmann B, Teng L, McBride T, Leimanis ML, English BK, Holsworth A, Frisch A, Bauss J, Kalpage N, Derbedrossian A, Pinti RM, Hale N, Mills J, Eby A, VanSickle EA, Pageau SC, Shankar R, Chen B, Carcillo JA, Sanfilippo D, Olivero R, Bupp CP, Rajasekaran S. High-Density Blood Transcriptomics Reveals Precision Immune Signatures of SARS-CoV-2 Infection in Hospitalized Individuals. Front Immunol 2021;12:694243. [PMID: 34335605 DOI: 10.3389/fimmu.2021.694243] [Reference Citation Analysis]
20 Nasonov EL. Coronavirus disease 2019 (COVID-19) and autoimmunity. Naučno-praktičeskaâ revmatologiâ 2021;59:5-30. [DOI: 10.47360/1995-4484-2021-5-30] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]
21 Wang R, Hu Q, Wang H, Zhu G, Wang M, Zhang Q, Zhao Y, Li C, Zhang Y, Ge G, Chen H, Chen L. Identification of Vitamin K3 and its analogues as covalent inhibitors of SARS-CoV-2 3CLpro. Int J Biol Macromol 2021;183:182-92. [PMID: 33901557 DOI: 10.1016/j.ijbiomac.2021.04.129] [Reference Citation Analysis]
22 Bernstein CN, Singh H, Murthy SK, Nguyen GC, Benchimol EI, Bitton A, Kuenzig ME, Huang JG, Jones JL, Lee K, Targownik LE, Windsor JW, Mukhtar MS, Tandon P, Kaplan GG. Crohn's and Colitis Canada's 2021 Impact of COVID-19 and Inflammatory Bowel Disease in Canada: Seniors With IBD. J Can Assoc Gastroenterol 2021;4:S34-9. [PMID: 34755037 DOI: 10.1093/jcag/gwab025] [Reference Citation Analysis]
23 Campello E, Radu CM, Simion C, Spiezia L, Bulato C, Gavasso S, Tormene D, Perin N, Turatti G, Simioni P. Longitudinal Trend of Plasma Concentrations of Extracellular Vesicles in Patients Hospitalized for COVID-19. Front Cell Dev Biol 2021;9:770463. [PMID: 35111751 DOI: 10.3389/fcell.2021.770463] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Cuker A, Tseng EK, Nieuwlaat R, Angchaisuksiri P, Blair C, Dane K, Davila J, DeSancho MT, Diuguid D, Griffin DO, Kahn SR, Klok FA, Lee AI, Neumann I, Pai A, Righini M, Sanfilippo KM, Siegal D, Skara M, Terrell DR, Touri K, Akl EA, Bou Akl I, Bognanni A, Boulos M, Brignardello-Petersen R, Charide R, Chan M, Dearness K, Darzi AJ, Kolb P, Colunga-Lozano LE, Mansour R, Morgano GP, Morsi RZ, Muti-Schünemann G, Noori A, Philip BA, Piggott T, Qiu Y, Roldan Y, Schünemann F, Stevens A, Solo K, Wiercioch W, Mustafa RA, Schünemann HJ. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients. Blood Adv 2021;5:3951-9. [PMID: 34474482 DOI: 10.1182/bloodadvances.2021005493] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Karikalan S, Sharma M, Chandna M, Sachdev M, Gaalla A, Yasmin F, Shah R, Ratnani I, Surani S. Intracardiac Thrombus in Coronavirus Disease-2019. Cureus. [DOI: 10.7759/cureus.22883] [Reference Citation Analysis]
26 Guervilly C, Bonifay A, Burtey S, Sabatier F, Cauchois R, Abdili E, Arnaud L, Lano G, Pietri L, Robert T, Velier M, Papazian L, Albanese J, Kaplanski G, Dignat-George F, Lacroix R. Dissemination of extreme levels of extracellular vesicles: tissue factor activity in patients with severe COVID-19. Blood Adv 2021;5:628-34. [PMID: 33560376 DOI: 10.1182/bloodadvances.2020003308] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
27 Advani R, Strømsnes TA, Stjernstrøm E, Lugg ST. Multiple simultaneous embolic cerebral infarctions 11 months after COVID-19. Thromb J 2021;19:57. [PMID: 34407847 DOI: 10.1186/s12959-021-00304-8] [Reference Citation Analysis]
28 Alharthy A, Faqihi F, Balhamar A, Memish ZA, Karakitsos D. Life-threatening COVID-19 presenting as stroke with antiphospholipid antibodies and low ADAMTS-13 activity, and the role of therapeutic plasma exchange: A case series. SAGE Open Med Case Rep 2020;8:2050313X20964089. [PMID: 33101686 DOI: 10.1177/2050313X20964089] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
29 Iba T, Warkentin TE, Thachil J, Levi M, Levy JH. Proposal of the Definition for COVID-19-Associated Coagulopathy. J Clin Med 2021;10:E191. [PMID: 33430431 DOI: 10.3390/jcm10020191] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 14.0] [Reference Citation Analysis]
30 Moubarak M, Kasozi KI, Hetta HF, Shaheen HM, Rauf A, Al-Kuraishy HM, Qusti S, Alshammari EM, Ayikobua ET, Ssempijja F, Afodun AM, Kenganzi R, Usman IM, Ochieng JJ, Osuwat LO, Matama K, Al-Gareeb AI, Kairania E, Musenero M, Welburn SC, Batiha GE. The Rise of SARS-CoV-2 Variants and the Role of Convalescent Plasma Therapy for Management of Infections. Life (Basel) 2021;11:734. [PMID: 34440478 DOI: 10.3390/life11080734] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
31 Quinaglia T, Shabani M, Breder I, Silber HA, Lima JAC, Sposito AC. Coronavirus disease-19: The multi-level, multi-faceted vasculopathy. Atherosclerosis 2021;322:39-50. [PMID: 33706082 DOI: 10.1016/j.atherosclerosis.2021.02.009] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
32 Melegari G, Rivi V, Zelent G, Nasillo V, De Santis E, Melegari A, Bevilacqua C, Zoli M, Meletti S, Barbieri A. Mild to Severe Neurological Manifestations of COVID-19: Cases Reports. Int J Environ Res Public Health 2021;18:3673. [PMID: 33915937 DOI: 10.3390/ijerph18073673] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
33 Raychaudhuri S, Pujani M, Menia R, Verma N, Singh M, Chauhan V, Jain M, Chandoke RK, Kaur H, Agrawal S, Singh A. COVID-19 Associated Coagulopathy in an Indian Scenario: A Correlation with Disease Severity and Survival Status. Indian J Hematol Blood Transfus 2021;:1-11. [PMID: 34426721 DOI: 10.1007/s12288-021-01465-2] [Reference Citation Analysis]
34 Bidar F, Hékimian G, Martin-Toutain I, Lebreton G, Combes A, Frère C. Heparin-induced thrombocytopenia in COVID-19 patients with severe acute respiratory distress syndrome requiring extracorporeal membrane oxygenation: two case reports. J Artif Organs 2021;24:277-81. [PMID: 32789604 DOI: 10.1007/s10047-020-01203-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
35 Shahidi-Dadras M, Shahrigharahkoshan S, Yazdi E, Fatemi A, Mahboubi-Fooladi Z, Dadkhahfar S. Sulfasalazine-Induced Toxic Epidermal Necrolysis: A Challenging Case During the COVID-19 Pandemic. Adv Emerg Nurs J 2021;43:194-7. [PMID: 34397495 DOI: 10.1097/TME.0000000000000361] [Reference Citation Analysis]
36 Reddy DH, Atam V, Rai P, Khan F, Pandey S, Malhotra HS, Gupta KK, Sonkar SK, Verma R, Usman K, Chaudhary SC, Sonkar SK, Kumar V, Sawlani KK, Gupta KK, Patel M, Himanshu D, Kumar A, Verma SK, Gautam M, Gupta H, Kumar S, Baghchandanani D, Yadav A, Lamba M, Kumar A, Suhail, Prabha R, Bajaj D, Singh AB, Mahendra M, Kumar G, Kumar N, Ojha BK, Verma R, Verma DK, Kumar V, Singh S, Gupta S, Hashim M, Verma K, Bhardwaj A, Chaudhary A, Chaudhan H, Kaustubh, Dubey K, Kumar N, Rituraj, Kumar J, Srivastav S, Singh SP, Kumari S, Srivastave S, Verma J, Hussain MA, Siddiqui AS, Rizvi A, Pancholi C, Sharma D, Verma DK, Zothansanga D, Singh K, Singh PK, Kumar R, Bharti VR, Ansari SA, Kumar V, Kallani M, Bharti H, Singh A, Majumdar A, Verma N, Mishra M, Gupta PK, Shivhare S, Kotwal M, Mahar P, Mall P, Parmar KS, Kumar G. COVID-19 cases and their outcome among patients with uncommon co-existing illnesses: A lesson from Northern India. Clinical Epidemiology and Global Health 2022. [DOI: 10.1016/j.cegh.2022.101044] [Reference Citation Analysis]
37 Mezgebe M, Jacobson BF, Mayne ES, Louw S. Change in platelet indices in patients with Coronavirus disease-2019 (COVID-19): A reflection of platelet activation and contribution to immunothrombosis? Int J Lab Hematol 2021. [PMID: 34519428 DOI: 10.1111/ijlh.13705] [Reference Citation Analysis]
38 Ruzicka JA. Identification of the antithrombotic protein S as a potential target of the SARS-CoV-2 papain-like protease. Thromb Res 2020;196:257-9. [PMID: 32920296 DOI: 10.1016/j.thromres.2020.09.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
39 Fernández-Sarmiento J, De Souza D, Jabornisky R, Gonzalez GA, Arias López MDP, Palacio G. Paediatric inflammatory multisystem syndrome temporally associated with COVID-19 (PIMS-TS): a narrative review and the viewpoint of the Latin American Society of Pediatric Intensive Care (SLACIP) Sepsis Committee. BMJ Paediatr Open 2021;5:e000894. [PMID: 34192188 DOI: 10.1136/bmjpo-2020-000894] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
40 Olwal CO, Nganyewo NN, Tapela K, Djomkam Zune AL, Owoicho O, Bediako Y, Duodu S. Parallels in Sepsis and COVID-19 Conditions: Implications for Managing Severe COVID-19. Front Immunol 2021;12:602848. [PMID: 33613574 DOI: 10.3389/fimmu.2021.602848] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 9.0] [Reference Citation Analysis]
41 Ray JG, Warkentin TE, Park AL. Heparin induced thrombocytopenia in relation to SARS-CoV-2 infection and ABO blood group. Thromb Res 2021;207:62-5. [PMID: 34555698 DOI: 10.1016/j.thromres.2021.09.008] [Reference Citation Analysis]
42 Cremer S, Pilgram L, Berkowitsch A, Stecher M, Rieg S, Shumliakivska M, Bojkova D, Wagner JUG, Aslan GS, Spinner C, Luxán G, Hanses F, Dolff S, Piepel C, Ruppert C, Guenther A, Rüthrich MM, Vehreschild JJ, Wille K, Haselberger M, Heuzeroth H, Hansen A, Eschenhagen T, Cinatl J, Ciesek S, Dimmeler S, Borgmann S, Zeiher A; LEOSS study group. Angiotensin II receptor blocker intake associates with reduced markers of inflammatory activation and decreased mortality in patients with cardiovascular comorbidities and COVID-19 disease. PLoS One 2021;16:e0258684. [PMID: 34673795 DOI: 10.1371/journal.pone.0258684] [Reference Citation Analysis]
43 Aribawa IGNM, Hidayat L, Dewi PU, Ryalino C. Progressive COVID-19-Associated Coagulopathy Despite Treatment with Therapeutic Anticoagulation and Thrombolysis. Am J Case Rep 2021;22:e930667. [PMID: 33967265 DOI: 10.12659/AJCR.930667] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
44 Elbeddini A, Gerochi R, Elshahawi A. Evaluation of the prophylaxis and treatment of COVID-associated coagulopathy. J Pharm Policy Pract 2020;13:73. [PMID: 33117545 DOI: 10.1186/s40545-020-00274-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
45 Saha A, Bajpai A, Krishna V, Bhattacharya S. Evolving Paradigm of Prothrombin Time Diagnostics with Its Growing Clinical Relevance towards Cardio-Compromised and COVID-19 Affected Population. Sensors (Basel) 2021;21:2636. [PMID: 33918646 DOI: 10.3390/s21082636] [Reference Citation Analysis]
46 Afari H, Tefera L, Rosovsky RP. Case of right ventricular and aortic thrombi in a patient with severe COVID-19. BMJ Case Rep 2021;14:e240745. [PMID: 33875503 DOI: 10.1136/bcr-2020-240745] [Reference Citation Analysis]
47 Vincent J, Levi M, Hunt BJ. Prevention and management of thrombosis in hospitalised patients with COVID-19 pneumonia. The Lancet Respiratory Medicine 2022;10:214-20. [DOI: 10.1016/s2213-2600(21)00455-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
48 Ray JG, Vermeulen MJ, Schull MJ, Park AL. ABO Blood Group, SARS-CoV-2 Infection, and Risk of Venous Thromboembolism: Population-Based Cohort Study. Clin Appl Thromb Hemost 2021;27:10760296211008986. [PMID: 33827287 DOI: 10.1177/10760296211008986] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
49 Savastano MC, Larici AR, Crincoli E, De Filippis A, Cicchetti G, Gambini G, Savastano A, Marano R, Natale L, Rizzo S. Retinal vascular impairment matched to the pulmonary damage in early post-COVID 19 patients. Eur J Ophthalmol 2022;:11206721221079153. [PMID: 35174719 DOI: 10.1177/11206721221079153] [Reference Citation Analysis]
50 Nekaeva ES, Bolshakova AE, Malysheva ES, Galova EA, Makarova EV, Nekrasova TA, Polyakova IV, Bedretdinova ZS, Belikina DV, Lavrenyuk AA, Fomin IV. Gender Characteristics of the Novel Coronavirus Infection (COVID-19) in Middle-Aged Adults. Sovrem Tekhnologii Med 2021;13:16-24. [PMID: 34603760 DOI: 10.17691/stm2021.13.4.02] [Reference Citation Analysis]
51 Martín-Rojas RM, Pérez-Rus G, Delgado-Pinos VE, Domingo-González A, Regalado-Artamendi I, Alba-Urdiales N, Demelo-Rodríguez P, Monsalvo S, Rodríguez-Macías G, Ballesteros M, Osorio-Prendes S, Díez-Martín JL, Pascual Izquierdo C. COVID-19 coagulopathy: An in-depth analysis of the coagulation system. Eur J Haematol 2020;105:741-50. [PMID: 32749010 DOI: 10.1111/ejh.13501] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 18.5] [Reference Citation Analysis]
52 Rahi MS, Jindal V, Reyes SP, Gunasekaran K, Gupta R, Jaiyesimi I. Hematologic disorders associated with COVID-19: a review. Ann Hematol 2021;100:309-20. [PMID: 33415422 DOI: 10.1007/s00277-020-04366-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
53 Schulze-Schiappacasse C, Alarcón-Andrade G, Valenzuela G, Ferreiro M, Cavagnaro A, García-Salum T, Gutiérrez M, Medina RA. Pulmonary Artery Thrombosis in a Newborn With Severe Coronavirus Disease 2019. Pediatr Infect Dis J 2021;40:e252-4. [PMID: 33956761 DOI: 10.1097/INF.0000000000003131] [Reference Citation Analysis]
54 Kamit F, Malbora B, Atay A, Bayirli DT, Bektas M. A Fatal Case of COVID-19 in a Child with ALL: A Cytokine Storm and Hyperferritinemic MODS. Journal of Child Science 2020;10:e240-5. [DOI: 10.1055/s-0040-1721513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
55 Zabolotnaya SV, Bogolepova AN, Tairova RT. [COVID-19-associated stroke]. Zh Nevrol Psikhiatr Im S S Korsakova 2021;121:5-10. [PMID: 34553575 DOI: 10.17116/jnevro20211210825] [Reference Citation Analysis]
56 Marvi TK, Stubblefield WB, Tillman BF, Tenforde MW, Patel MM, Lindsell CJ, Self WH, Grijalva CG, Rice TW; for the Influenza and Other Viruses in the Acutely Ill (IVY) Network. Serial Thromboelastography and the Development of Venous Thromboembolism in Critically Ill Patients With COVID-19. Critical Care Explorations 2022;4:e0618. [DOI: 10.1097/cce.0000000000000618] [Reference Citation Analysis]
57 Park J, Kim H, Kim SY, Kim Y, Lee JS, Dan K, Seong MW, Han D. In-depth blood proteome profiling analysis revealed distinct functional characteristics of plasma proteins between severe and non-severe COVID-19 patients. Sci Rep 2020;10:22418. [PMID: 33376242 DOI: 10.1038/s41598-020-80120-8] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 8.0] [Reference Citation Analysis]
58 Zifkos K, Dubois C, Schäfer K. Extracellular Vesicles and Thrombosis: Update on the Clinical and Experimental Evidence. Int J Mol Sci 2021;22:9317. [PMID: 34502228 DOI: 10.3390/ijms22179317] [Reference Citation Analysis]
59 Bell R, Zini G, d'Onofrio G, Rogers HJ, Lee YS, Frater JL. The hematology laboratory's response to the COVID-19 pandemic: A scoping review. Int J Lab Hematol. 2021;43:148-159. [PMID: 33180380 DOI: 10.1111/ijlh.13381] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Tomerak S, Khan S, Almasri M, Hussein R, Abdelati A, Aly A, Salameh MA, Saed Aldien A, Naveed H, Elshazly MB, Zakaria D. Systemic inflammation in COVID‐19 patients may induce various types of venous and arterial thrombosis: A systematic review. Scand J Immunol 2021;94. [DOI: 10.1111/sji.13097] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
61 Anwar N, Tashfeen S, Akhtar F, Noor A, Khan SA, Omair A. Can disseminated intravascular coagulation scores predict mortality in COVID-19 patients? J Taibah Univ Med Sci 2021;16:596-604. [PMID: 33850513 DOI: 10.1016/j.jtumed.2021.03.002] [Reference Citation Analysis]
62 Villar M, Urra JM, Rodríguez-Del-Río FJ, Artigas-Jerónimo S, Jiménez-Collados N, Ferreras-Colino E, Contreras M, de Mera IGF, Estrada-Peña A, Gortázar C, de la Fuente J. Characterization by Quantitative Serum Proteomics of Immune-Related Prognostic Biomarkers for COVID-19 Symptomatology. Front Immunol 2021;12:730710. [PMID: 34566994 DOI: 10.3389/fimmu.2021.730710] [Reference Citation Analysis]
63 Carsetti A, Damiani E, Casarotta E, Scorcella C, Domizi R, Montomoli J, Gasparri F, Gabbanelli V, Pantanetti S, Carozza R, Adrario E, Donati A. Sublingual microcirculation in patients with SARS-CoV-2 undergoing veno-venous extracorporeal membrane oxygenation. Microvasc Res 2020;132:104064. [PMID: 32841626 DOI: 10.1016/j.mvr.2020.104064] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
64 Mohan G, Wilson W, Paonam B, Vaidya A, Ravindra P, Shastry S, Balakrishnan JM, Rao S, Chaudhuri S. Utility of Thromboelastography and velocity curve derivative in diagnosing COVID-19 associated coagulopathy. Int J Lab Hematol 2022. [PMID: 35609623 DOI: 10.1111/ijlh.13876] [Reference Citation Analysis]
65 Loo J, Spittle DA, Newnham M. COVID-19, immunothrombosis and venous thromboembolism: biological mechanisms. Thorax 2021;76:412-20. [PMID: 33408195 DOI: 10.1136/thoraxjnl-2020-216243] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 25.0] [Reference Citation Analysis]
66 Odom CV, Kim Y, Burgess CL, Baird LA, Korkmaz FT, Na E, Shenoy AT, Arafa EI, Lam TT, Jones MR, Mizgerd JP, Traber KE, Quinton LJ. Liver-Dependent Lung Remodeling during Systemic Inflammation Shapes Responses to Secondary Infection. J Immunol 2021;207:1891-902. [PMID: 34470857 DOI: 10.4049/jimmunol.2100254] [Reference Citation Analysis]
67 LaFond E, Weidman K, Lief L. Care of the postcoronavirus disease 2019 patient. Curr Opin Pulm Med 2021;27:199-204. [PMID: 33606410 DOI: 10.1097/MCP.0000000000000767] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Smirnov AV, Ermilov VV, Dorofeev NA, Tolokolnikov VA, Chernetsky OA, Poplavsky AE, Botasheva VS, Samusev RP, Alexandrova LI, Belik TA, Makarova MM, Gurov DY. [Features of pathological anatomy of COVID-19 according to autopsy results in the Volgograd Region]. Arkh Patol 2021;83:5-13. [PMID: 34859980 DOI: 10.17116/patol2021830615] [Reference Citation Analysis]
69 Ayyildiz A, Çobaner N, Yelken B. Sepsis induced coagulopathy score and D-dimer levels in COVID-19 patients followed in intensive care; what has changed in COVID era? Journal of Health Sciences and Medicine 2022;5:94-8. [DOI: 10.32322/jhsm.992132] [Reference Citation Analysis]
70 Subramanyam K, Johny D, Bhat S, Raghothama S. De novo right ventricular thrombus in a COVID-19-positive patient. BMJ Case Rep 2021;14:e247380. [PMID: 34794982 DOI: 10.1136/bcr-2021-247380] [Reference Citation Analysis]
71 Kantarcioglu B, Iqbal O, Walenga JM, Lewis B, Lewis J, Carter CA, Singh M, Lievano F, Tafur A, Ramacciotti E, Gerotziafas GT, Jeske W, Fareed J. An Update on the Pathogenesis of COVID-19 and the Reportedly Rare Thrombotic Events Following Vaccination. Clin Appl Thromb Hemost 2021;27:10760296211021498. [PMID: 34060379 DOI: 10.1177/10760296211021498] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
72 Tomo S, Kumar KP, Roy D, Sankanagoudar S, Purohit P, Yadav D, Banerjee M, Sharma P, Misra S. Complement activation and coagulopathy - an ominous duo in COVID19. Expert Rev Hematol 2021;14:155-73. [PMID: 33480807 DOI: 10.1080/17474086.2021.1875813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
73 Otsubo S, Wakabayashi S, Aoyama Y, Kinoshita K, Minami M, Ohsima Y, Kobayashi S, Otsubo Y. Characteristics of hemodialysis patient with critical COVID-19. Ther Apher Dial 2021. [PMID: 34870889 DOI: 10.1111/1744-9987.13773] [Reference Citation Analysis]
74 Meazza Prina M, Martini F, Bracchi F, Di Mauro D, Fargnoli A, Motta M, Giussani C, Gobbin G, Taverna M, D'Alessio A. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report. BMC Infect Dis 2021;21:811. [PMID: 34388982 DOI: 10.1186/s12879-021-06532-7] [Reference Citation Analysis]
75 Othman M, Baker AT, Gupalo E, Elsebaie A, Bliss CM, Rondina MT, Lillicrap D, Parker AL. To clot or not to clot? Ad is the question-Insights on mechanisms related to vaccine-induced thrombotic thrombocytopenia. J Thromb Haemost 2021. [PMID: 34351057 DOI: 10.1111/jth.15485] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
76 García de Guadiana-Romualdo L, Morell-García D, Favaloro EJ, Vílchez JA, Bauça JM, Alcaide Martín MJ, Gutiérrez Garcia I, de la Hera Cagigal P, Egea-Caparrós JM, Pérez Sanmartín S, Gutiérrez Revilla JI, Urrechaga E, Álamo JM, Hernando Holgado AM, Lorenzo-Lozano MC, Canalda Campás M, Juncos Tobarra MA, Morales-Indiano C, Vírseda Chamorro I, Pastor Murcia Y, Sahuquillo Frías L, Altimira Queral L, Nuez-Zaragoza E, Adell Ruiz de León J, Ruiz Ripa A, Salas Gómez-Pablos P, Cebreiros López I, Fernández Uriarte A, Larruzea A, López Yepes ML, Sancho-Rodríguez N, Zamorano Andrés MC, Pedregosa Díaz J, Sáenz L, Esparza Del Valle C, Baamonde Calzada MC, García Muñoz S, Vera M, Martín Torres E, Sánchez Fdez-Pacheco S, Vicente Gutiérrez L, Jiménez Añón L, Pérez Martínez A, Pons Castillo A, González Tamayo R, Férriz Vivancos J, Rodríguez-Fraga O, Díaz-Brito V, Aguadero V, García Arévalo MG, Arnaldos Carrillo M, González Morales M, Núñez Gárate M, Ruiz Iruela C, Esteban Torrella P, Vila Pérez M, Acevedo Alcaraz C, Blázquez-Manzanera AL, Galán Ortega A. Harmonized D-dimer levels upon admission for prognosis of COVID-19 severity: Results from a Spanish multicenter registry (BIOCOVID-Spain study). J Thromb Thrombolysis 2021. [PMID: 34272635 DOI: 10.1007/s11239-021-02527-y] [Reference Citation Analysis]
77 Bull BS, Hay KL, Herrmann PC. Fibrin Strands Will Grow from Soluble Fibrin and Hang Up in an In Vitro Microcirculatory Viscoelastic Model: Is This a Major Cause of COVID-19 Associated Coagulopathy? JCM 2022;11:2084. [DOI: 10.3390/jcm11082084] [Reference Citation Analysis]
78 Tilinca MC, Gliga MC, Varga A. The Pathophysiology and Management of Diabetic Ketoacidosis in COVID-19 Patients: A Literature Review. The Journal of Critical Care Medicine 2021;0. [DOI: 10.2478/jccm-2021-0024] [Reference Citation Analysis]
79 Christie F, Quasim T, Cowan R, King K, McPeake J. Meralgia paraesthetica in intensive care unit survivors of COVID-19. Anaesthesia 2021;76:712-3. [PMID: 33351958 DOI: 10.1111/anae.15355] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
80 Voicu S, Ketfi C, Stépanian A, Chousterman BG, Mohamedi N, Siguret V, Mebazaa A, Mégarbane B, Bonnin P. Pathophysiological Processes Underlying the High Prevalence of Deep Vein Thrombosis in Critically Ill COVID-19 Patients. Front Physiol 2020;11:608788. [PMID: 33488398 DOI: 10.3389/fphys.2020.608788] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
81 Shah A, Dave S, Galvagno S, George K, Menne AR, Haase DJ, McCormick B, Rector R, Dahi S, Madathil RJ, Deatrick KB, Ghoreishi M, Gammie JS, Kaczorowski DJ, Scalea TM, Menaker J, Herr D, Tabatabai A, Krause E. A Dedicated Veno-Venous Extracorporeal Membrane Oxygenation Unit during a Respiratory Pandemic: Lessons Learned from COVID-19 Part II: Clinical Management. Membranes (Basel) 2021;11:306. [PMID: 33919390 DOI: 10.3390/membranes11050306] [Reference Citation Analysis]
82 Nakatsutsumi K, Endo A, Okuzawa H, Onishi I, Koyanagi A, Nagaoka E, Morishita K, Aiboshi J, Otomo Y. Colon perforation as a complication of COVID-19: a case report. Surg Case Rep 2021;7:175. [PMID: 34347185 DOI: 10.1186/s40792-021-01261-0] [Reference Citation Analysis]
83 Zhang A, Leng Y, Zhang Y, Wu K, Ji Y, Lei S, Xia Z. Meta-analysis of coagulation parameters associated with disease severity and poor prognosis of COVID-19. Int J Infect Dis 2020;100:441-8. [PMID: 32947052 DOI: 10.1016/j.ijid.2020.09.021] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 6.5] [Reference Citation Analysis]
84 Ahmed M, Gaba WH, Al Mazrouei SS. Neuro-imaging manifestations of COVID-19: Predilection for PICA infarcts. IDCases 2021;24:e01131. [PMID: 33898251 DOI: 10.1016/j.idcr.2021.e01131] [Reference Citation Analysis]
85 Tsivgoulis G, Palaiodimou L, Zand R, Lioutas VA, Krogias C, Katsanos AH, Shoamanesh A, Sharma VK, Shahjouei S, Baracchini C, Vlachopoulos C, Gournellis R, Sfikakis PP, Sandset EC, Alexandrov AV, Tsiodras S. COVID-19 and cerebrovascular diseases: a comprehensive overview. Ther Adv Neurol Disord 2020;13:1756286420978004. [PMID: 33343709 DOI: 10.1177/1756286420978004] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 9.0] [Reference Citation Analysis]
86 Campello E, Bulato C, Spiezia L, Boscolo A, Poletto F, Cola M, Gavasso S, Simion C, Radu CM, Cattelan A, Tiberio I, Vettor R, Navalesi P, Simioni P. Thrombin generation in patients with COVID-19 with and without thromboprophylaxis. Clin Chem Lab Med 2021;59:1323-30. [PMID: 33544518 DOI: 10.1515/cclm-2021-0108] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
87 Xiong Y, Ma Y, Tian Y, Zhang C, Yang W, Liu B, Ruan L, Lu C, Huang L. A Longitudinal Cohort Study Using a Modified Child-Pugh Score to Escalate Respiratory Support in COVID-19 Patients - Hubei Province, China, 2020. China CDC Wkly 2021;3:423-9. [PMID: 34594905 DOI: 10.46234/ccdcw2021.113] [Reference Citation Analysis]
88 Kantarcioglu B, Darki A, Siddiqui F, Hoppensteadt D, Lewis J, Krämer R, Adiguzel C, Fareed J. The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients. Clin Appl Thromb Hemost 2022;28:107602962210917. [DOI: 10.1177/10760296221091770] [Reference Citation Analysis]
89 Schrottmaier WC, Pirabe A, Pereyra D, Heber S, Hackl H, Schmuckenschlager A, Brunnthaler L, Santol J, Kammerer K, Oosterlee J, Pawelka E, Treiber SM, Khan AO, Pugh M, Traugott MT, Schörgenhofer C, Seitz T, Karolyi M, Jilma B, Rayes J, Zoufaly A, Assinger A. Adverse Outcome in COVID-19 Is Associated With an Aggravating Hypo-Responsive Platelet Phenotype. Front Cardiovasc Med 2021;8:795624. [PMID: 34957266 DOI: 10.3389/fcvm.2021.795624] [Reference Citation Analysis]
90 Jungwirth-Weinberger A, Bendich I, Hanreich C, Gonzalez Della Valle A, Blevins JL, Westrich GH, Boettner F. History of COVID-19 infection is not associated with increased D-dimer levels and risk of deep-vein thrombosis in total joint arthroplasty. Arch Orthop Trauma Surg 2021. [PMID: 34546422 DOI: 10.1007/s00402-021-04181-8] [Reference Citation Analysis]
91 Leentjens J, van Haaps TF, Wessels PF, Schutgens REG, Middeldorp S. COVID-19-associated coagulopathy and antithrombotic agents-lessons after 1 year. Lancet Haematol 2021;8:e524-33. [PMID: 33930350 DOI: 10.1016/S2352-3026(21)00105-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
92 Assinger A. COVID-19-related prothrombotic changes increase with lung injury and remain unaffected by anticoagulation therapy. Res Pract Thromb Haemost 2021;5:11-3. [PMID: 33537524 DOI: 10.1002/rth2.12473] [Reference Citation Analysis]
93 Silva TF, Tomiotto-Pellissier F, Sanfelice RA, Gonçalves MD, da Silva Bortoleti BT, Detoni MB, Rodrigues ACJ, Carloto ACM, Concato VM, Siqueira EDS, Costa IN, Pavanelli WR, Conchon-Costa I, Miranda-Sapla MM. A 21st Century Evil: Immunopathology and New Therapies of COVID-19. Front Immunol 2020;11:562264. [PMID: 33193331 DOI: 10.3389/fimmu.2020.562264] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
94 Shovlin CL, Vizcaychipi MP. Vascular inflammation and endothelial injury in SARS-CoV-2 infection: The overlooked regulatory cascades implicated by the ACE2 gene cluster. QJM 2020:hcaa241. [PMID: 32777054 DOI: 10.1093/qjmed/hcaa241] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
95 Patel A, Ajayi F, Ali R, Chan KH, Slim J. Dilemma of Anticoagulation Therapy in Mild or Asymptomatic COVID-19 Cases. Cureus 2021;13:e19291. [PMID: 34900472 DOI: 10.7759/cureus.19291] [Reference Citation Analysis]
96 de Almeida DC, Franco MDCP, Dos Santos DRP, Santos MC, Maltoni IS, Mascotte F, de Souza AA, Pietrobom PM, Medeiros EA, Ferreira PRA, Machado FR, Goes MA. Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients. PLoS One 2021;16:e0251048. [PMID: 34033655 DOI: 10.1371/journal.pone.0251048] [Reference Citation Analysis]
97 Schmid A, Petrovic M, Akella K, Pareddy A, Velavan SS. Getting to the Heart of the Matter: Myocardial Injury, Coagulopathy, and Other Potential Cardiovascular Implications of COVID-19. Int J Vasc Med 2021;2021:6693895. [PMID: 34035963 DOI: 10.1155/2021/6693895] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
98 Beaulieu MC, Mettelus DS, Rioux-Massé B, Mahone M. Thrombotic thrombocytopenic purpura as the initial presentation of COVID-19. J Thromb Haemost 2021;19:1132-4. [PMID: 33382912 DOI: 10.1111/jth.15231] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
99 Chashchin MG, Gorshkov AY, Drapkina OM. Acute coronary syndrome in COVID-19 patients. Cardiovasc Ther Prev 2021;20:2806. [DOI: 10.15829/1728-8800-2021-2806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
100 Kleineberg NN, Knauss S, Gülke E, Pinnschmidt HO, Jakob CEM, Lingor P, Hellwig K, Berthele A, Höglinger G, Fink GR, Endres M, Gerloff C, Klein C, Stecher M, Classen AY, Rieg S, Borgmann S, Hanses F, Rüthrich MM, Hower M, Tometten L, Haselberger M, Piepel C, Merle U, Dolff S, Degenhardt C, Jensen BO, Vehreschild MJGT, Erber J, Franke C, Warnke C; LEOSS Study Group. Neurological symptoms and complications in predominantly hospitalized COVID-19 patients: Results of the European multinational Lean European Open Survey on SARS-Infected Patients (LEOSS). Eur J Neurol 2021. [PMID: 34411383 DOI: 10.1111/ene.15072] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
101 Smorenberg A, Peters EJ, van Daele P, Nossent EJ, Muller M. How does SARS-CoV-2 targets the elderly patients? A review on potential mechanisms increasing disease severity. Eur J Intern Med 2021;83:1-5. [PMID: 33303345 DOI: 10.1016/j.ejim.2020.11.024] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
102 Reisi-Vanani V, Lorigooini Z, Dayani MA, Mardani M, Rahmani F. Massive intraperitoneal hemorrhage in patients with COVID-19: a case series. J Thromb Thrombolysis 2021;52:338-44. [PMID: 33909261 DOI: 10.1007/s11239-021-02447-x] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
103 Safak S, Aksoy E, Dirim AB, Demir E, Garayeva N, Oto OA, Artan AS, Yazici H, Besisik S, Turkmen A. Successful treatment of a COVID-19 patient with thrombotic microangiopathy. Clin Kidney J 2021;14:1287-8. [PMID: 34094522 DOI: 10.1093/ckj/sfab024] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
104 Uzun G, Althaus K, Hammer S, Bakchoul T. Assessment and Monitoring of Coagulation in Patients with COVID-19: A Review of Current Literature. Hamostaseologie 2022. [PMID: 35477118 DOI: 10.1055/a-1755-8676] [Reference Citation Analysis]
105 Jeyalan V, Storrar J, Wu HHL, Ponnusamy A, Sinha S, Kalra PA, Chinnadurai R. Native and transplant kidney histopathological manifestations in association with COVID-19 infection: A systematic review. World J Transplant 2021; 11(11): 480-502 [PMID: 34868898 DOI: 10.5500/wjt.v11.i11.480] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
106 Abd El-lateef AE, Alghamdi S, Ebid G, Khalil K, Kabrah S, Abdel Ghafar MT. Coagulation Profile in COVID-19 Patients and its Relation to Disease Severity and Overall Survival: A Single-Center Study. Br J Biomed Sci 2022;79:10098. [DOI: 10.3389/bjbs.2022.10098] [Reference Citation Analysis]
107 Siepmann T, Barlinn K. [Association of COVID-19 and Stroke: Pathophysiology and Clinical Relevance]. Fortschr Neurol Psychiatr 2021;89:289-95. [PMID: 34020462 DOI: 10.1055/a-1484-0224] [Reference Citation Analysis]
108 Osuchowski MF, Winkler MS, Skirecki T, Cajander S, Shankar-Hari M, Lachmann G, Monneret G, Venet F, Bauer M, Brunkhorst FM, Weis S, Garcia-Salido A, Kox M, Cavaillon JM, Uhle F, Weigand MA, Flohé SB, Wiersinga WJ, Almansa R, de la Fuente A, Martin-Loeches I, Meisel C, Spinetti T, Schefold JC, Cilloniz C, Torres A, Giamarellos-Bourboulis EJ, Ferrer R, Girardis M, Cossarizza A, Netea MG, van der Poll T, Bermejo-Martín JF, Rubio I. The COVID-19 puzzle: deciphering pathophysiology and phenotypes of a new disease entity. Lancet Respir Med 2021;9:622-42. [PMID: 33965003 DOI: 10.1016/S2213-2600(21)00218-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 17.0] [Reference Citation Analysis]
109 Zhu C, Sun B, Zhang X, Zhang B. Research Progress of Genetic Structure, Pathogenic Mechanism, Clinical Characteristics, and Potential Treatments of Coronavirus Disease 2019. Front Pharmacol 2020;11:1327. [PMID: 32973534 DOI: 10.3389/fphar.2020.01327] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
110 Zhang P, Heyman T, Greechan M, Dygulska B, Al Sayyed F, Narula P, Lederman S. Maternal, neonatal and placental characteristics of SARS-CoV-2 positive mothers. The Journal of Maternal-Fetal & Neonatal Medicine. [DOI: 10.1080/14767058.2021.1892637] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
111 Sayed Ahmed HA, Merrell E, Ismail M, Joudeh AI, Riley JB, Shawkat A, Habeb H, Darling E, Goweda RA, Shehata MH, Amin H, Nieman GF, Aiash H. Rationales and uncertainties for aspirin use in COVID-19: a narrative review. Fam Med Community Health 2021;9:e000741. [PMID: 33879541 DOI: 10.1136/fmch-2020-000741] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
112 Shankar A, Varadan B, Ethiraj D, Sudarsanam H, Hakeem AR, Kalyanasundaram S. Systemic arterio-venous thrombosis in COVID-19: A pictorial review. World J Radiol 2021; 13(1): 19-28 [PMID: 33574991 DOI: 10.4329/wjr.v13.i1.19] [Reference Citation Analysis]
113 Falter T, Rossmann H, Menge P, Goetje J, Groenwoldt S, Weinmann A, Sivanathan V, Schulz A, Lemmermann NAW, Danckwardt S, Lackner KJ, Galle PR, Scharrer I, Lämmle B, Sprinzl MF. No Evidence for Classic Thrombotic Microangiopathy in COVID-19. J Clin Med 2021;10:671. [PMID: 33572417 DOI: 10.3390/jcm10040671] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
114 Mongula JE, Frenken MWE, van Lijnschoten G, Arents NLA, de Wit-Zuurendonk LD, Schimmel-de Kok APA, van Runnard Heimel PJ, Porath MM, Goossens SMTA. COVID-19 during pregnancy: non-reassuring fetal heart rate, placental pathology and coagulopathy. Ultrasound Obstet Gynecol 2020;56:773-6. [PMID: 32853442 DOI: 10.1002/uog.22189] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
115 Mehta JL, Calcaterra G, Bassareo PP. COVID-19, thromboembolic risk, and Virchow's triad: Lesson from the past. Clin Cardiol 2020;43:1362-7. [PMID: 33176009 DOI: 10.1002/clc.23460] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
116 Xu Z, Xu Y, Liu D, Liu X, Zhou L, Huang Y, Li Y, Liu X. Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19. Front Med (Lausanne) 2021;8:681548. [PMID: 34422856 DOI: 10.3389/fmed.2021.681548] [Reference Citation Analysis]
117 Ko CJ, Harigopal M, Gehlhausen JR, Bosenberg M, McNiff JM, Damsky W. Discordant anti-SARS-CoV-2 spike protein and RNA staining in cutaneous perniotic lesions suggests endothelial deposition of cleaved spike protein. J Cutan Pathol 2021;48:47-52. [PMID: 32895985 DOI: 10.1111/cup.13866] [Cited by in Crossref: 9] [Cited by in F6Publishing: 12] [Article Influence: 4.5] [Reference Citation Analysis]
118 Greenway A, Leahy N, Torrieri L, An A, Fink SA, Witenko C, Shikar M, Winchell RJ, Barie PS, Liu SI. Skin Failure Among Critically Ill Patients Afflicted with Coronavirus Disease 2019 (COVID-19). J Intensive Care Med 2021;36:1331-9. [PMID: 34591701 DOI: 10.1177/08850666211046532] [Reference Citation Analysis]
119 Riva G, Nasillo V, Tagliafico E, Trenti T, Comoli P, Luppi M. COVID-19: more than a cytokine storm. Crit Care 2020;24:549. [PMID: 32887652 DOI: 10.1186/s13054-020-03267-w] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
120 Jiménez D, Torres Arias M. Immunouniverse of SARS-CoV-2. Immunol Med 2022;:1-39. [PMID: 35502127 DOI: 10.1080/25785826.2022.2066251] [Reference Citation Analysis]
121 Sebuhyan M, Mirailles R, Crichi B, Frere C, Bonnin P, Bergeron-Lafaurie A, Denis B, Liegeon G, Peyrony O, Farge D; Saint-Louis CORE (COVID-19 RESEARCH) group. How to screen and diagnose deep venous thrombosis (DVT) in patients hospitalized for or suspected of COVID-19 infection, outside the intensive care units. J Med Vasc 2020;45:334-43. [PMID: 33248536 DOI: 10.1016/j.jdmv.2020.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
122 Kalafatis M. Covid-19: A Serious Vascular Disease With Primary Symptoms Of A Respiratory Ailment. J Appl Lab Med 2021:jfab084. [PMID: 34240194 DOI: 10.1093/jalm/jfab084] [Reference Citation Analysis]
123 Levy JH, Iba T, Gardiner EE. Endothelial Injury in COVID-19 and Acute Infections: Putting the Pieces of the Puzzle Together. Arterioscler Thromb Vasc Biol 2021;41:1774-6. [PMID: 33792345 DOI: 10.1161/ATVBAHA.121.316101] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
124 Waite AAC, Hamilton DO, Pizzi R, Ageno W, Welters ID. Hypercoagulopathy in Severe COVID-19: Implications for Acute Care. Thromb Haemost 2020;120:1654-67. [PMID: 33368088 DOI: 10.1055/s-0040-1721487] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
125 Ten Cate H, Leader A. Management of Disseminated Intravascular Coagulation in Acute Leukemias. Hamostaseologie 2021;41:120-6. [PMID: 33860520 DOI: 10.1055/a-1393-8302] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
126 Mellema RA, Crandell J, Petrey AC. Platelet Dysregulation in the Pathobiology of COVID-19. Hamostaseologie 2021. [PMID: 34879421 DOI: 10.1055/a-1646-3392] [Reference Citation Analysis]
127 Lenihan D, Carver J, Porter C, Liu JE, Dent S, Thavendiranathan P, Mitchell JD, Nohria A, Fradley MG, Pusic I, Stockerl-Goldstein K, Blaes A, Lyon AR, Ganatra S, López-Fernández T, O'Quinn R, Minotti G, Szmit S, Cardinale D, Alvarez-Cardona J, Curigliano G, Neilan TG, Herrmann J. Cardio-oncology care in the era of the coronavirus disease 2019 (COVID-19) pandemic: An International Cardio-Oncology Society (ICOS) statement. CA Cancer J Clin 2020;70:480-504. [PMID: 32910493 DOI: 10.3322/caac.21635] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
128 Criado PR, Miot HA, Pincelli TPH, Fabro AT. From dermatological conditions to COVID-19: Reasoning for anticoagulation, suppression of inflammation, and hyperbaric oxygen therapy. Dermatol Ther 2021;34:e14565. [PMID: 33219572 DOI: 10.1111/dth.14565] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
129 Fenyves BG, Mehta A, Kays KR, Goldberg MB, Hacohen N, Filbin MR; MGH COVID-19 Collection & Processing Team. Plasma P-selectin is an early marker of thromboembolism in COVID-19. medRxiv 2021:2021. [PMID: 34282425 DOI: 10.1101/2021.07.10.21260293] [Reference Citation Analysis]
130 Comer SP, Cullivan S, Szklanna PB, Weiss L, Cullen S, Kelliher S, Smolenski A, Murphy C, Altaie H, Curran J, O'Reilly K, Cotter AG, Marsh B, Gaine S, Mallon P, McCullagh B, Moran N, Ní Áinle F, Kevane B, Maguire PB; COCOON Study investigators. COVID-19 induces a hyperactive phenotype in circulating platelets. PLoS Biol 2021;19:e3001109. [PMID: 33596198 DOI: 10.1371/journal.pbio.3001109] [Cited by in Crossref: 19] [Cited by in F6Publishing: 23] [Article Influence: 19.0] [Reference Citation Analysis]
131 Orso D, Mattuzzi L, Scapol S, Delrio S, Vetrugno L, Bove T. Phlegmasia cerulea dolens superimposed on disseminated intravascular coagulation in COVID-19. Acta Biomed 2021;92:e2021101. [PMID: 34487073 DOI: 10.23750/abm.v92i4.11478] [Reference Citation Analysis]
132 Jin K, Bardes EE, Mitelpunkt A, Wang JY, Bhatnagar S, Sengupta S, Krummel DP, Rothenberg ME, Aronow BJ. Implicating Gene and Cell Networks Responsible for Differential COVID-19 Host Responses via an Interactive Single Cell Web Portal. bioRxiv 2021:2021. [PMID: 34127975 DOI: 10.1101/2021.06.07.447287] [Reference Citation Analysis]
133 Vavougios GD, Ntoskas KT, Doskas TK. Impairment in selenocysteine synthesis as a candidate mechanism of inducible coagulopathy in COVID-19 patients. Med Hypotheses 2021;147:110475. [PMID: 33421689 DOI: 10.1016/j.mehy.2020.110475] [Reference Citation Analysis]
134 Nagori EK, Smith R, Sorto F, Hasan M. Development of Arterial Thrombosis in a Patient on Therapeutic Anticoagulation for COVID-19. Cureus 2021;13:e17644. [PMID: 34646692 DOI: 10.7759/cureus.17644] [Reference Citation Analysis]
135 Sharma S, Wood M, Gulli G. COVID-19-associated ischaemic stroke despite use of anticoagulation. BMJ Case Rep 2021;14:e243741. [PMID: 34326115 DOI: 10.1136/bcr-2021-243741] [Reference Citation Analysis]
136 Delrue M, Siguret V, Neuwirth M, Joly B, Beranger N, Sène D, Chousterman BG, Voicu S, Bonnin P, Mégarbane B, Stépanian A. von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients. Br J Haematol 2021;192:1097-100. [PMID: 33368196 DOI: 10.1111/bjh.17216] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
137 Sandoval M, Nguyen DT, Vahidy FS, Graviss EA. Risk factors for severity of COVID-19 in hospital patients age 18-29 years. PLoS One 2021;16:e0255544. [PMID: 34329347 DOI: 10.1371/journal.pone.0255544] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
138 Ostaszewski M, Niarakis A, Mazein A, Kuperstein I, Phair R, Orta-Resendiz A, Singh V, Aghamiri SS, Acencio ML, Glaab E, Ruepp A, Fobo G, Montrone C, Brauner B, Frishman G, Monraz Gómez LC, Somers J, Hoch M, Kumar Gupta S, Scheel J, Borlinghaus H, Czauderna T, Schreiber F, Montagud A, Ponce de Leon M, Funahashi A, Hiki Y, Hiroi N, Yamada TG, Dräger A, Renz A, Naveez M, Bocskei Z, Messina F, Börnigen D, Fergusson L, Conti M, Rameil M, Nakonecnij V, Vanhoefer J, Schmiester L, Wang M, Ackerman EE, Shoemaker JE, Zucker J, Oxford K, Teuton J, Kocakaya E, Summak GY, Hanspers K, Kutmon M, Coort S, Eijssen L, Ehrhart F, Rex DAB, Slenter D, Martens M, Pham N, Haw R, Jassal B, Matthews L, Orlic-Milacic M, Senff Ribeiro A, Rothfels K, Shamovsky V, Stephan R, Sevilla C, Varusai T, Ravel JM, Fraser R, Ortseifen V, Marchesi S, Gawron P, Smula E, Heirendt L, Satagopam V, Wu G, Riutta A, Golebiewski M, Owen S, Goble C, Hu X, Overall RW, Maier D, Bauch A, Gyori BM, Bachman JA, Vega C, Grouès V, Vazquez M, Porras P, Licata L, Iannuccelli M, Sacco F, Nesterova A, Yuryev A, de Waard A, Turei D, Luna A, Babur O, Soliman S, Valdeolivas A, Esteban-Medina M, Peña-Chilet M, Rian K, Helikar T, Puniya BL, Modos D, Treveil A, Olbei M, De Meulder B, Ballereau S, Dugourd A, Naldi A, Noël V, Calzone L, Sander C, Demir E, Korcsmaros T, Freeman TC, Augé F, Beckmann JS, Hasenauer J, Wolkenhauer O, Wilighagen EL, Pico AR, Evelo CT, Gillespie ME, Stein LD, Hermjakob H, D'Eustachio P, Saez-Rodriguez J, Dopazo J, Valencia A, Kitano H, Barillot E, Auffray C, Balling R, Schneider R; COVID-19 Disease Map Community. COVID19 Disease Map, a computational knowledge repository of virus-host interaction mechanisms. Mol Syst Biol 2021;17:e10387. [PMID: 34664389 DOI: 10.15252/msb.202110387] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
139 de la Morena-Barrio ME, Bravo-Pérez C, Miñano A, de la Morena-Barrio B, Fernandez-Perez MP, Bernal E, Gómez-Verdu JM, Herranz MT, Vicente V, Corral J, Lozano ML. Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients. Sci Rep 2021;11:7792. [PMID: 33833254 DOI: 10.1038/s41598-021-85906-y] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
140 Kell DB, Laubscher GJ, Pretorius E. A central role for amyloid fibrin microclots in long COVID/PASC: origins and therapeutic implications. Biochem J 2022;479:537-59. [PMID: 35195253 DOI: 10.1042/BCJ20220016] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
141 Schrottmaier WC, Pirabe A, Pereyra D, Heber S, Hackl H, Schmuckenschlager A, Brunnthaler L, Santol J, Kammerer K, Oosterlee J, Pawelka E, Treiber SM, Khan AO, Pugh M, Traugott MT, Schörgenhofer C, Seitz T, Karolyi M, Jilma B, Rayes J, Zoufaly A, Assinger A. Platelets and Antiplatelet Medication in COVID-19-Related Thrombotic Complications. Front Cardiovasc Med 2022;8:802566. [DOI: 10.3389/fcvm.2021.802566] [Reference Citation Analysis]
142 Brenner B, Ay C, Le Gal G, Carrier M, Muñoz AJ, Agnelli G, Cavalcanti Rocha AT, Abdel-razeq H, Elalamy I, Falanga A. Venous thromboembolism risk, prophylaxis and management in cancer patients with COVID-19: An unmet medical need. Thrombosis Update 2022. [DOI: 10.1016/j.tru.2022.100098] [Reference Citation Analysis]
143 Faqihi F, Alharthy A, Balhamar A, Nasim N, Alanezi K, Alaklobi F, Memish ZA, Blaivas M, Alqahtani SA, Karakitsos D. A Retrospective Analysis of Thromboembolic Phenomena in Mechanically Ventilated Patients with COVID-19. Crit Care Res Pract 2021;2021:8737580. [PMID: 33520314 DOI: 10.1155/2021/8737580] [Reference Citation Analysis]
144 Sanjay S MRCS(Edin), MS(Oph), DNB(Oph), MMed(Oph)(SIN), MNAMS, Bhakti Mistra S DNB(Oph), Patro SK MD(Community medicine), Kawali A DNB (Oph), Shetty R FRCS(Glasgow), PhD(Maastricht), DNB(Oph), Mahendradas P DO, DNB(Oph). Systemic Markers in Ophthalmic Manifestations of Post Corona Virus Disease-19 (COVID-19). Ocul Immunol Inflamm 2022;:1-6. [PMID: 35138993 DOI: 10.1080/09273948.2021.2025253] [Reference Citation Analysis]
145 Kobelev E, Bergen TA, Tarkova AR, Vasiltseva OY, Kamenskaya OV, Usov VY, Chernyavsky AM. COVID-19 as a cause of chronic pulmonary hypertension: pathophysiological rationale and potential of instrumental investigations. Cardiovasc Ther Prev 2021;20:2844. [DOI: 10.15829/1728-8800-2021-2844] [Reference Citation Analysis]
146 Nadim MK, Forni LG, Mehta RL, Connor MJ Jr, Liu KD, Ostermann M, Rimmelé T, Zarbock A, Bell S, Bihorac A, Cantaluppi V, Hoste E, Husain-Syed F, Germain MJ, Goldstein SL, Gupta S, Joannidis M, Kashani K, Koyner JL, Legrand M, Lumlertgul N, Mohan S, Pannu N, Peng Z, Perez-Fernandez XL, Pickkers P, Prowle J, Reis T, Srisawat N, Tolwani A, Vijayan A, Villa G, Yang L, Ronco C, Kellum JA. COVID-19-associated acute kidney injury: consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 2020;16:747-64. [PMID: 33060844 DOI: 10.1038/s41581-020-00356-5] [Cited by in Crossref: 38] [Cited by in F6Publishing: 92] [Article Influence: 19.0] [Reference Citation Analysis]
147 Levi M. Pathophysiology of Coagulopathy in Hematological Malignancies and in COVID-19. Hemasphere 2021;5:e571. [PMID: 34095755 DOI: 10.1097/HS9.0000000000000571] [Reference Citation Analysis]
148 Miltiades A, Houck PJ, Monteleone M, Harrison NL, Cabrera-Garcia D, Roh D, Wagener G. Insights into Fibrinogen-Mediated COVID-19 Hypercoagubility in Critically Ill Patients. J Neurosurg Anesthesiol 2022;34:136-40. [PMID: 34870637 DOI: 10.1097/ANA.0000000000000812] [Reference Citation Analysis]
149 Olgers TJ, Lieveld AWE, Kok B, Heijmans J, Salet D, Assman NL, Postma DF, Bauer MP, Nanayakkara PWB, Meijer K, Bosch FH, Kooistra H. Screening for asymptomatic deep vein thrombosis in COVID-19 patients admitted to the medical ward: a cross-sectional study. J Ultrasound 2022. [PMID: 35567703 DOI: 10.1007/s40477-022-00689-w] [Reference Citation Analysis]
150 Matli K, Farah R, Maalouf M, Chamoun N, Costanian C, Ghanem G. Role of combining anticoagulant and antiplatelet agents in COVID-19 treatment: a rapid review. Open Heart 2021;8:e001628. [PMID: 34099529 DOI: 10.1136/openhrt-2021-001628] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
151 Venter C, Bezuidenhout JA, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB, Pretorius E. Erythrocyte, Platelet, Serum Ferritin, and P-Selectin Pathophysiology Implicated in Severe Hypercoagulation and Vascular Complications in COVID-19. Int J Mol Sci 2020;21:E8234. [PMID: 33153161 DOI: 10.3390/ijms21218234] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
152 Valle EO, Cabrera CPS, Albuquerque CCC, Silva GVD, Oliveira MFA, Sales GTM, Smolentzov I, Reichert BV, Andrade L, Seabra VF, Lins PRG, Rodrigues CE. Continuous renal replacement therapy in COVID-19-associated AKI: adding heparin to citrate to extend filter life-a retrospective cohort study. Crit Care 2021;25:299. [PMID: 34412667 DOI: 10.1186/s13054-021-03729-9] [Reference Citation Analysis]
153 Jin Y, Ji W, Yang H, Chen S, Zhang W, Duan G. Endothelial activation and dysfunction in COVID-19: from basic mechanisms to potential therapeutic approaches.Signal Transduct Target Ther. 2020;5:293. [PMID: 33361764 DOI: 10.1038/s41392-020-00454-7] [Cited by in Crossref: 55] [Cited by in F6Publishing: 50] [Article Influence: 27.5] [Reference Citation Analysis]
154 Mouliou DS, Pantazopoulos I, Gourgoulianis KI. COVID-19 smart diagnosis in the Emergency Department: all-in in practice. Expert Rev Respir Med 2022. [PMID: 35245149 DOI: 10.1080/17476348.2022.2049760] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
155 Aghayari Sheikh Neshin S, Shahjouei S, Koza E, Friedenberg I, Khodadadi F, Sabra M, Kobeissy F, Ansari S, Tsivgoulis G, Li J, Abedi V, Wolk DM, Zand R. Stroke in SARS-CoV-2 Infection: A Pictorial Overview of the Pathoetiology. Front Cardiovasc Med 2021;8:649922. [PMID: 33855053 DOI: 10.3389/fcvm.2021.649922] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
156 Dugbartey GJ, Alornyo KK, Ohene BO, Boima V, Antwi S, Sener A. Renal consequences of the novel coronavirus disease 2019 (COVID-19) and hydrogen sulfide as a potential therapy. Nitric Oxide 2022;120:16-25. [PMID: 35032641 DOI: 10.1016/j.niox.2022.01.002] [Reference Citation Analysis]
157 Kantarcioglu B, Iqbal O, Lewis J, Carter CA, Singh M, Lievano F, Ligocki M, Jeske W, Adiguzel C, Gerotziafas GT, Fareed J. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations. Clin Appl Thromb Hemost 2022;28:107602962110566. [DOI: 10.1177/10760296211056648] [Reference Citation Analysis]
158 Pretorius E, Venter C, Laubscher GJ, Lourens PJ, Steenkamp J, Kell DB. Prevalence of readily detected amyloid blood clots in 'unclotted' Type 2 Diabetes Mellitus and COVID-19 plasma: a preliminary report. Cardiovasc Diabetol 2020;19:193. [PMID: 33203441 DOI: 10.1186/s12933-020-01165-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
159 Al-Subaie AM. Coagulopathies in novel coronavirus (SARS-CoV-2) pandemic: Emerging evidence for hematologists. Saudi J Biol Sci 2021;28:956-61. [PMID: 33169062 DOI: 10.1016/j.sjbs.2020.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
160 Faqihi F, Alharthy A, Abdulaziz S, Balhamar A, Alomari A, AlAseri Z, Tamim H, Alqahtani SA, Kutsogiannis DJ, Brindley PG, Karakitsos D, Memish ZA. Therapeutic plasma exchange in patients with life-threatening COVID-19: a randomised controlled clinical trial. Int J Antimicrob Agents 2021;57:106334. [PMID: 33838224 DOI: 10.1016/j.ijantimicag.2021.106334] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
161 Iba T, Connors JM, Spyropoulos AC, Wada H, Levy JH. Ethnic differences in thromboprophylaxis for COVID-19 patients: should they be considered? Int J Hematol 2021;113:330-6. [PMID: 33471294 DOI: 10.1007/s12185-021-03078-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
162 Robinson PC, Liew DFL, Liew JW, Monaco C, Richards D, Shivakumar S, Tanner HL, Feldmann M. The Potential for Repurposing Anti-TNF as a Therapy for the Treatment of COVID-19. Med (N Y) 2020;1:90-102. [PMID: 33294881 DOI: 10.1016/j.medj.2020.11.005] [Cited by in Crossref: 16] [Cited by in F6Publishing: 21] [Article Influence: 8.0] [Reference Citation Analysis]
163 Lim MS, Mcrae S. COVID-19 and immunothrombosis: Pathophysiology and therapeutic implications. Crit Rev Oncol Hematol 2021;168:103529. [PMID: 34800652 DOI: 10.1016/j.critrevonc.2021.103529] [Reference Citation Analysis]
164 Ceci Bonello E, Casha R, Xerri T, Bonello J, Fsadni C, Mallia Azzopardi C. Multiorgan thrombosis as a complication of COVID-19 pneumonia. BMJ Case Rep 2021;14:e243953. [PMID: 34321271 DOI: 10.1136/bcr-2021-243953] [Reference Citation Analysis]
165 D'Elia E, Gori M, Grosu A, Iorio A, Lorini FL, Falanga A, Di Marco F, Senni M. An unexpected case of recurrence of pulmonary embolism in a patient recovered from COVID19 in full regimen dose of direct oral anticoagulant drug. BMC Pulm Med 2021;21:102. [PMID: 33761886 DOI: 10.1186/s12890-021-01453-2] [Reference Citation Analysis]
166 McAlpine LS, Zubair AS, Maran I, Chojecka P, Lleva P, Jasne AS, Navaratnam D, Matouk C, Schindler J, Sheth KN, Chun H, Lee AI, Spudich S, Sharma R, Sansing LH. Ischemic Stroke, Inflammation, and Endotheliopathy in COVID-19 Patients. Stroke 2021;52:e233-8. [PMID: 33966492 DOI: 10.1161/STROKEAHA.120.031971] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
167 Almskog LM, Wikman A, Svensson J, Bottai M, Kotormán M, Wahlgren C, Wanecek M, van der Linden J, Ågren A. Hypercoagulation Detected by Rotational Thromboelastometry Predicts Mortality in COVID-19: A Risk Model Based on a Prospective Observational Study. TH Open 2022;06:e50-9. [DOI: 10.1055/a-1725-9221] [Reference Citation Analysis]
168 Zhao X, Tao M, Chen C, Zhang Y, Fu Y. Clinical Features and Factors Associated with Occult Gastrointestinal Bleeding in COVID-19 Patients. Infect Drug Resist 2021;14:4217-26. [PMID: 34703248 DOI: 10.2147/IDR.S335868] [Reference Citation Analysis]
169 Go AS, Reynolds K, Tabada GH, Prasad PA, Sung SH, Garcia E, Portugal C, Fan D, Pai AP, Fang MC. COVID-19 and Risk of VTE in Ethnically Diverse Populations. Chest 2021:S0012-3692(21)01353-2. [PMID: 34293316 DOI: 10.1016/j.chest.2021.07.025] [Reference Citation Analysis]
170 Abdeen S, Bdeir K, Abu-Fanne R, Maraga E, Higazi M, Khurram N, Feldman M, Deshpande C, Litzky LA, Heyman SN, Montone KT, Cines DB, Higazi AA. Alpha-defensins: risk factor for thrombosis in COVID-19 infection. Br J Haematol 2021;194:44-52. [PMID: 34053084 DOI: 10.1111/bjh.17503] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
171 Goudarzi S, Firouzabadi FD, Mahmoudzadeh F, Aminimoghaddam S. Pulmonary embolism in pregnancy with COVID-19 infection: A case report. Clin Case Rep 2021. [PMID: 33821188 DOI: 10.1002/ccr3.3709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
172 Kofteridis DP, Ioannou P, Kondili E, Chamilos G, Filippatos TD. Personalized prophylactic anticoagulation in hospitalized patients with Covid-19 - The role of anti-Xa monitoring. Clin Microbiol Infect 2021;27:1188-9. [PMID: 33933565 DOI: 10.1016/j.cmi.2021.04.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
173 Delshad M, Safaroghli-Azar A, Pourbagheri-Sigaroodi A, Poopak B, Shokouhi S, Bashash D. Platelets in the perspective of COVID-19; pathophysiology of thrombocytopenia and its implication as prognostic and therapeutic opportunity. Int Immunopharmacol 2021;99:107995. [PMID: 34304001 DOI: 10.1016/j.intimp.2021.107995] [Reference Citation Analysis]
174 Aquino L, Muniz JC, Laufer PM, Prieto LR. Gore Cardioform ASD device thrombus weeks after COVID-19 infection. Catheter Cardiovasc Interv 2022. [PMID: 35018709 DOI: 10.1002/ccd.30067] [Reference Citation Analysis]
175 Leslie-Mazwi TM, Srivatanakul K. Coronavirus disease 2019 and stroke. Interv Neuroradiol 2021;27:13-8. [PMID: 34670419 DOI: 10.1177/15910199211035920] [Reference Citation Analysis]
176 Dhar S, Bhattacharjee P. Promising role of curcumin against viral diseases emphasizing COVID-19 management: A review on the mechanistic insights with reference to host-pathogen interaction and immunomodulation. J Funct Foods 2021;82:104503. [PMID: 33897833 DOI: 10.1016/j.jff.2021.104503] [Reference Citation Analysis]
177 Demeulemeester F, de Punder K, van Heijningen M, van Doesburg F. Obesity as a Risk Factor for Severe COVID-19 and Complications: A Review. Cells 2021;10:933. [PMID: 33920604 DOI: 10.3390/cells10040933] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
178 Iba T, Levy JH. Thrombosis and thrombocytopenia in COVID-19 and after COVID-19 vaccination. Trends Cardiovasc Med 2022:S1050-1738(22)00038-X. [PMID: 35202800 DOI: 10.1016/j.tcm.2022.02.008] [Reference Citation Analysis]
179 Melgaço JG, Brito E Cunha D, Azamor T, da Silva AMV, Tubarão LN, Gonçalves RB, Monteiro RQ, Missailidis S, da Costa Neves PC, Ano Bom APD. Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS-CoV-2): Challenges to Near-Future Breakthroughs. J Immunol Res 2020;2020:8827670. [PMID: 33426096 DOI: 10.1155/2020/8827670] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
180 Yamada S, Asakura H. Coagulopathy and Fibrinolytic Pathophysiology in COVID-19 and SARS-CoV-2 Vaccination. IJMS 2022;23:3338. [DOI: 10.3390/ijms23063338] [Reference Citation Analysis]
181 Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy. Expert Rev Respir Med 2021;15:1003-11. [PMID: 33667146 DOI: 10.1080/17476348.2021.1899815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
182 Sharathkumar AA, Faustino EVS, Takemoto CM. How we approach thrombosis risk in children with COVID-19 infection and MIS-C. Pediatr Blood Cancer 2021;68:e29049. [PMID: 33955167 DOI: 10.1002/pbc.29049] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
183 Zhao B, Liu M, Liu P, Peng Y, Huang J, Li M, Wang Y, Xu L, Sun S, Qi X, Ling Y, Li J, Zhang W, Mao E, Qu J. High Dose Intravenous Vitamin C for Preventing The Disease Aggravation of Moderate COVID-19 Pneumonia. A Retrospective Propensity Matched Before-After Study. Front Pharmacol 2021;12:638556. [PMID: 33967773 DOI: 10.3389/fphar.2021.638556] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]